Springer Nature
Browse
40880_2019_424_MOESM1_ESM.docx (12.44 kB)

MOESM1 of Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1–Survivin axis

Download (12.44 kB)
journal contribution
posted on 2019-12-04, 04:37 authored by Jun-Hai Tang, Lin Yang, Ju-Xiang Chen, Qing-Rui Li, Li-Rong Zhu, Qing-Fu Xu, Guo-Hao Huang, Zuo-Xin Zhang, Yan Xiang, Lei Du, Zheng Zhou, Sheng-Qing Lv
Additional file 1: Table S1. Antibodies for immunofluorescent, Western blotting, and immunohistochemical staining.

Funding

National Natural Science Foundation of China

History

Usage metrics

    Chinese Journal of Cancer

    Categories

    Keywords

    GliomaBortezomibFOXM1SurvivinTemozolomide (TMZ)Chemotherapy

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC